Estrogen's effect on brain support cells and why Alzheimer's hits women harder
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
['FUNDING_R01'] · NORTHWESTERN UNIVERSITY · NIH-11457045
This project looks at whether low estrogen causes changes in brain support cells called astrocytes that raise Alzheimer's risk in women.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-11457045 on ClinicalTrials.gov |
What this research studies
Scientists use mouse models that lack the aromatase enzyme in the brain or throughout the body to mimic estrogen deficiency and compare males and females. They measure memory and neuron counts, treat some mice with a selective estrogen receptor alpha (ERα) drug that previously rescued memory in female mice, and analyze brain tissue with RNA sequencing, qPCR, and immunofluorescence to detect astrocyte reactivity and gene changes. Results so far show older female mice with whole-body estrogen loss have memory loss, fewer hippocampal neurons, and signs of reactive astrocytes, while males do not. The team plans to link these animal findings to human Alzheimer's biology to help guide future treatment ideas.
Who could benefit from this research
Good fit: People living with Alzheimer's disease—especially women and postmenopausal women concerned about hormone-related risk—would be most relevant to follow this research and could be candidates for related future clinical trials.
Not a fit: People with non-Alzheimer's dementias or whose disease is unlikely linked to estrogen signaling may not directly benefit from these findings.
Why it matters
Potential benefit: If confirmed, this work could point to estrogen-related or astrocyte-targeted treatments to lower Alzheimer's risk or slow decline in women.
How similar studies have performed: Previous animal studies have shown that boosting estrogen signaling can improve memory in estrogen-deficient female mice, but human testing of estrogen-based approaches for Alzheimer's has been limited and results are mixed.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHAO, HONG — NORTHWESTERN UNIVERSITY
- Study coordinator: ZHAO, HONG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.